Healthcare | March 23, 2023
OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Time to combine innovation, access and technology to deliver positive patient outcomes
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Subscribe To Our Newsletter & Stay Updated
